Literature DB >> 10729333

Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases.

D Frey1, C Schneider, L Xu, J Borg, W Spooren, P Caroni.   

Abstract

The addition or loss of synapses in response to changes in activity, disease, or aging is a major aspect of nervous system plasticity in the adult. The mechanisms that affect the turnover and maintenance of synapses in the adult are poorly understood and are difficult to investigate in the brain. Here, we exploited a unique anatomical arrangement in the neuromuscular system to determine whether subtypes of synapses can differ in anatomical plasticity and vulnerability. In three genetic mouse models of motoneuron disease of diverse origin and severity, we observed a gradual and selective loss of synaptic connections that begun long before the onset of clinical deficits and correlated with the timing of disease progression. A subgroup of fast-type (fast-fatiguable) neuromuscular synapses was highly vulnerable and was lost very early on. In contrast, slow-type synapses resisted up to the terminal phase of the disease. Muscle-specific differences were also evident. Similar selective losses were detected in aged mice. These selective vulnerability properties of synapses coincided with hitherto unrecognized major differences in stimulus-induced anatomical plasticity that could also be revealed in healthy mice. Using paralysis and/or growth-associated protein 43 overexpression to induce synaptic sprouting, we found that slow-type, disease-resistant synapses were particularly plastic. In contrast, fast-type synapses with the highest vulnerability failed to exhibit any stimulus-induced change. The results reveal pronounced subtype specificity in the anatomical plasticity and susceptibility to loss of neuromuscular synapses and suggest that degenerative motoneuron diseases involve a common early pathway of selective and progressive synaptic weakening also associated with aging.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729333      PMCID: PMC6772256     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  26 in total

1.  Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: differences between fast and slow muscles.

Authors:  L W Duchen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-02       Impact factor: 10.154

2.  Correlation of electrophysiology with pathology, pathogenesis, and anticholinesterase therapy in post-polio syndrome.

Authors:  N R Cashman; D A Trojan
Journal:  Ann N Y Acad Sci       Date:  1995-05-25       Impact factor: 5.691

3.  Neuromuscular transmission in amyotrophic lateral sclerosis.

Authors:  R A Maselli; R L Wollman; C Leung; B Distad; S Palombi; D P Richman; E F Salazar-Grueso; R P Roos
Journal:  Muscle Nerve       Date:  1993-11       Impact factor: 3.217

4.  Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons.

Authors:  T L Williamson; D W Cleveland
Journal:  Nat Neurosci       Date:  1999-01       Impact factor: 24.884

5.  Effects of 4-aminopyridine on muscle and motor unit force in canine motor neuron disease.

Authors:  M J Pinter; R F Waldeck; T C Cope; L C Cork
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

6.  Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Authors:  A Y Chiu; P Zhai; M C Dal Canto; T M Peters; Y W Kwon; S M Prattis; M E Gurney
Journal:  Mol Cell Neurosci       Date:  1995-08       Impact factor: 4.314

7.  GAP-43 and p75NGFR immunoreactivity in presynaptic cells following neuromuscular blockade by botulinum toxin in rat.

Authors:  S M Hassan; F G Jennekens; H Veldman; B A Oestreicher
Journal:  J Neurocytol       Date:  1994-06

8.  Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant.

Authors:  T L Williamson; L I Bruijn; Q Zhu; K L Anderson; S D Anderson; J P Julien; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase.

Authors:  S Couillard-Després; Q Zhu; P C Wong; D L Price; D W Cleveland; J P Julien
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

View more
  250 in total

Review 1.  Links between electrophysiological and molecular pathology of amyotrophic lateral sclerosis.

Authors:  Katharina A Quinlan
Journal:  Integr Comp Biol       Date:  2011-10-11       Impact factor: 3.326

2.  Sprouting capacity of lumbar motoneurons in normal and hemisected spinal cords of the rat.

Authors:  T Gordon; N Tyreman
Journal:  J Physiol       Date:  2010-06-02       Impact factor: 5.182

3.  A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease.

Authors:  Tennore Ramesh; Alison N Lyon; Ricardo H Pineda; Chunping Wang; Paul M L Janssen; Benjamin D Canan; Arthur H M Burghes; Christine E Beattie
Journal:  Dis Model Mech       Date:  2010-05-26       Impact factor: 5.758

Review 4.  Axon Guidance Molecules and Neural Circuit Remodeling After Spinal Cord Injury.

Authors:  Edmund R Hollis
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

5.  Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice.

Authors:  C Tallon; K A Russell; S Sakhalkar; N Andrapallayal; M H Farah
Journal:  Neuroscience       Date:  2015-11-18       Impact factor: 3.590

6.  The Psi(m) depolarization that accompanies mitochondrial Ca2+ uptake is greater in mutant SOD1 than in wild-type mouse motor terminals.

Authors:  Khanh T Nguyen; Luis E García-Chacón; John N Barrett; Ellen F Barrett; Gavriel David
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

7.  Glial cell line-derived neurotrophic factor (GDNF) expression and NMJ plasticity in skeletal muscle following endurance exercise.

Authors:  A M Gyorkos; M J McCullough; J M Spitsbergen
Journal:  Neuroscience       Date:  2013-11-08       Impact factor: 3.590

8.  Characterization of intercostal muscle pathology in canine degenerative myelopathy: a disease model for amyotrophic lateral sclerosis.

Authors:  Brandie R Morgan; Joan R Coates; Gayle C Johnson; Alyssa C Bujnak; Martin L Katz
Journal:  J Neurosci Res       Date:  2013-09-16       Impact factor: 4.164

9.  Stem cell derived phenotypic human neuromuscular junction model for dose response evaluation of therapeutics.

Authors:  Navaneetha Santhanam; Lee Kumanchik; Xiufang Guo; Frank Sommerhage; Yunqing Cai; Max Jackson; Candace Martin; George Saad; Christopher W McAleer; Ying Wang; Andrea Lavado; Christopher J Long; James J Hickman
Journal:  Biomaterials       Date:  2018-02-27       Impact factor: 12.479

10.  Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease.

Authors:  Douglas Ashley Monks; Jamie A Johansen; Kaiguo Mo; Pengcheng Rao; Bryn Eagleson; Zhigang Yu; Andrew P Lieberman; S Marc Breedlove; Cynthia L Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.